These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8540724)

  • 1. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.
    Oh YK; Nix DE; Straubinger RM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2104-11. PubMed ID: 8540724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.
    Majumdar S; Flasher D; Friend DS; Nassos P; Yajko D; Hadley WK; Düzgüneş N
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2808-15. PubMed ID: 1482150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-encapsulated antibiotics.
    Salem II; Flasher DL; Düzgüneş N
    Methods Enzymol; 2005; 391():261-91. PubMed ID: 15721386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azithromycin and Mycobacterium avium infection].
    Perronne C
    Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.
    Leitzke S; Bucke W; Borner K; Müller R; Hahn H; Ehlers S
    Antimicrob Agents Chemother; 1998 Feb; 42(2):459-61. PubMed ID: 9527808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of intracellular Mycobacterium avium complex infection by free and liposome-encapsulated sparfloxacin.
    Düzgüneş N; Flasher D; Reddy MV; Luna-Herrera J; Gangadharam PR
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2618-21. PubMed ID: 8913475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of anti-bacterial drug and anti-mycobacterial drug for drug delivery system.
    Yanagihara K
    Curr Pharm Des; 2002; 8(6):475-82. PubMed ID: 12069384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin.
    Blanchard JD; Elias V; Cipolla D; Gonda I; Bermudez LE
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis.
    Mehta RT; Keyhani A; McQueen TJ; Rosenbaum B; Rolston KV; Tarrand JJ
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2584-7. PubMed ID: 8109920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Study and Attempt of Treatment of Mycobacteriosis Caused by Mycobacterium avium in a Parental Flock of Meat-Breed Pigeons.
    Ledwoń A; Miąsko M; Napiórkowska A; Augustynowicz-Kopeć E; Parniewski P; Majchrzak M; Czopowicz M; Adamczyk K; Bonecka J; Szeleszczuk P
    Avian Dis; 2020 Sep; 64(3):335-342. PubMed ID: 33205182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation.
    Zaru M; Sinico C; De Logu A; Caddeo C; Lai F; Manca ML; Fadda AM
    J Liposome Res; 2009; 19(1):68-76. PubMed ID: 19515009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of clarithromycin, azithromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony-stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare.
    Onyeji CO; Nightingale CH; Tessier PR; Nicolau DP; Bow LM
    J Infect Dis; 1995 Sep; 172(3):810-6. PubMed ID: 7658075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial efficacy against an in vivo Salmonella typhimurium infection model and pharmacokinetics of a liposomal ciprofloxacin formulation.
    Webb MS; Boman NL; Wiseman DJ; Saxon D; Sutton K; Wong KF; Logan P; Hope MJ
    Antimicrob Agents Chemother; 1998 Jan; 42(1):45-52. PubMed ID: 9449259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.
    Onyeji CO; Nightingale CH; Nicolau DP; Quintiliani R
    Antimicrob Agents Chemother; 1994 Mar; 38(3):523-7. PubMed ID: 8203849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
    Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
    N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection.
    Mehta RT
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1893-902. PubMed ID: 8843300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
    Wong JP; Yang H; Blasetti KL; Schnell G; Conley J; Schofield LN
    J Control Release; 2003 Oct; 92(3):265-73. PubMed ID: 14568408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
    Seral C; Carryn S; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.
    Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS
    Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection.
    Peters K; Leitzke S; Diederichs JE; Borner K; Hahn H; Müller RH; Ehlers S
    J Antimicrob Chemother; 2000 Jan; 45(1):77-83. PubMed ID: 10629016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.